Search research articles
Contact Us
Filters
Showing results (1-10 of 9) with videos related to
Page
of 1
Sort By:
Journal of Biomolecular Structure & Dynamics
|
November 3, 2020
Multi-conformational frame from molecular dynamics as a structure-based pharmacophore model for mapping, screening and identifying ligands against PPAR-γ: a new protocol to develop promising candidates
P Prabitha, Dhivya Shanmugarajan, T Durai Ananda Kumar, et al.
Chemical Biology & Drug Design
|
August 9, 2007
4-Cyclohexyl-1-substituted-4H-[1,2,4]triazolo [4,3-a] quinazolin-5-ones: novel class of H1-antihistaminic agents
V Alagarsamy, S Meena, K V Ramaseshu, et al.
ACS Chemical Neuroscience
|
June 14, 2021
Glitazones Activate PGC-1α Signaling via PPAR-γ: A Promising Strategy for Antiparkinsonism Therapeutics
Prabitha P, Antony Justin, T Durai Ananda Kumar, et al.
Journal of Ethnopharmacology
|
May 27, 2021
Chemical profiling and in-vitro anti-inflammatory activity of bioactive fraction(s) from Trichodesma indicum (L.) R.Br. against LPS induced inflammation in RAW 264.7 murine macrophage cells
Hamsalakshmi, Suresh Joghee, Sreeram P Kalarikkal, et al.
Chemical Biology & Drug Design
|
August 28, 2007
Synthesis of novel 3-butyl-2-substituted amino-3H-quinazolin-4-ones as analgesic and anti-inflammatory agents
V Alagarsamy, S Meena, K V Ramaseshu, et al.
Computational Biology and Chemistry
|
November 18, 2021
A promising in silico protocol to develop novel PPARγ antagonists as potential anticancer agents: Design, synthesis and experimental validation via PPARγ protein activity and competitive binding assay
Yuvaraj Sivamani, Dhivya Shanmugarajan, T Durai Ananda Kumar, et al.
Bioorganic & Medicinal Chemistry
|
September 24, 2025
Decades old glitazones still find niche in drug discoveries as PPAR-γ agonists: medicinal chemistry perspective, structure-activity relationships and therapeutic implications
P Archana, T Durai Ananda Kumar, N Vijaya Ganesh, et al.
European Journal of Medicinal Chemistry
|
June 14, 2021
Lysophosphatidic acid (LPA) receptor modulators: Structural features and recent development
Bhagyalalitha Meduri, Gurubasavaraj Veeranna Pujar, T Durai Ananda Kumar, et al.
Frontiers in Pharmacology
|
May 25, 2026
Metabolites extracted from browntop millet (Urochloa ramosa (L.) T.Q. Nguyen) mitigated the proliferation of breast- and colorectal carcinoma cells <i>in vitro</i> and retarded the EAC tumors <i>in vivo</i> by binding to oncogenic proteins
Mahadevaswamy G Kuruburu, Venugopal R Bovilla, Rimshia Naaz, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 9) with videos related to
Sort By:
Page
of 1
Journal of Biomolecular Structure & Dynamics
|
November 3, 2020
Multi-conformational frame from molecular dynamics as a structure-based pharmacophore model for mapping, screening and identifying ligands against PPAR-γ: a new protocol to develop promising candidates
P Prabitha, Dhivya Shanmugarajan, T Durai Ananda Kumar, et al.
Chemical Biology & Drug Design
|
August 9, 2007
4-Cyclohexyl-1-substituted-4H-[1,2,4]triazolo [4,3-a] quinazolin-5-ones: novel class of H1-antihistaminic agents
V Alagarsamy, S Meena, K V Ramaseshu, et al.
ACS Chemical Neuroscience
|
June 14, 2021
Glitazones Activate PGC-1α Signaling via PPAR-γ: A Promising Strategy for Antiparkinsonism Therapeutics
Prabitha P, Antony Justin, T Durai Ananda Kumar, et al.
Journal of Ethnopharmacology
|
May 27, 2021
Chemical profiling and in-vitro anti-inflammatory activity of bioactive fraction(s) from Trichodesma indicum (L.) R.Br. against LPS induced inflammation in RAW 264.7 murine macrophage cells
Hamsalakshmi, Suresh Joghee, Sreeram P Kalarikkal, et al.
Chemical Biology & Drug Design
|
August 28, 2007
Synthesis of novel 3-butyl-2-substituted amino-3H-quinazolin-4-ones as analgesic and anti-inflammatory agents
V Alagarsamy, S Meena, K V Ramaseshu, et al.
Computational Biology and Chemistry
|
November 18, 2021
A promising in silico protocol to develop novel PPARγ antagonists as potential anticancer agents: Design, synthesis and experimental validation via PPARγ protein activity and competitive binding assay
Yuvaraj Sivamani, Dhivya Shanmugarajan, T Durai Ananda Kumar, et al.
Bioorganic & Medicinal Chemistry
|
September 24, 2025
Decades old glitazones still find niche in drug discoveries as PPAR-γ agonists: medicinal chemistry perspective, structure-activity relationships and therapeutic implications
P Archana, T Durai Ananda Kumar, N Vijaya Ganesh, et al.
European Journal of Medicinal Chemistry
|
June 14, 2021
Lysophosphatidic acid (LPA) receptor modulators: Structural features and recent development
Bhagyalalitha Meduri, Gurubasavaraj Veeranna Pujar, T Durai Ananda Kumar, et al.
Frontiers in Pharmacology
|
May 25, 2026
Metabolites extracted from browntop millet (Urochloa ramosa (L.) T.Q. Nguyen) mitigated the proliferation of breast- and colorectal carcinoma cells <i>in vitro</i> and retarded the EAC tumors <i>in vivo</i> by binding to oncogenic proteins
Mahadevaswamy G Kuruburu, Venugopal R Bovilla, Rimshia Naaz, et al.
Page
of 1